Lupin Ltd. NSE: LUPIN | BSE: 500257

Mid-range Performer

1933.20 13.40 (0.70%)

1.5M

NSE+BSE Volume

NSE 29 Sep, 2025 3:59 PM (IST)

Acquisition

Lupin's arm to buy Amsterdam-based VISUfarma B.V. for €190 million to expand its European presence See details

Lupin Ltd. quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents